SEEL Research and Charts

SEEL - Seelos Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-16 (Delayed quote data 2025-04-10)

Last 0.00	Change ⇓ 0.00 (0.00%)	Volume 64
	Open 0.00	High 0.00	Low 0.00

8EMA (Daily) 0.00	40EMA (Daily) 0.03	50EMA (Daily) 0.09	STO (Daily) 0.000	MACD Hist (Daily) 0.009
8EMA (Weekly) 0.020	40EMA (Weekly) 81.46	50EMA (Weekly) 174.63	STO (Weekly) 0.000	MACD Hist (Weekly) 20.898


Company Profile
Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address significant unmet needs in the Central Nervous System ("CNS") disorders and other rare disorders.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.